21567 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds Pretargeting
MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES
#2BIOORTHOGONAL COMPOSITIONS
#3ANTI-CD38 SINGLE DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT
#4COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY
#5EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS
#6ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO SAID CELLS
#7MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES
#8MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY
#9PRE-TARGETING IMAGING AGENTS
#10ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO SAID CELLS
#11Compositions, delivery systems, and methods useful in tumor therapy
#12BIOORTHOGONAL COMPOSITIONS
#13ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS
#14COMPOSITIONS AND METHODS FOR IMAGING
#15TETRAZINES FOR HIGH CLICK CONJUGATION YIELD IN VIVO AND HIGH CLICK RELEASE YIELD
#16POLYPEPT(O)ID-BASED GRAFT COPOLYMERS FOR IN VIVO IMAGING BY TETRAZINE TRANSYCLOOCTENE CLICK CHEMISTRY
#17COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS
#18ENHANCEMENT OF PATHOGEN IMMUNOGENICITY
#19TCO conjugates and methods for delivery of therapeutic agents
#20BIOORTHOGONAL COMPOSITIONS
#21Modular self assembly disassembly (SADA) technologies
#22TCO conjugates and methods for delivery of therapeutic agents
#23Bioorthogonal compositions
#24Trifunctional and completely clearable specific targeting agents and methods thereof
#25RADIOACTIVE MEDICAL DEVICE
#26TCO conjugates and methods for delivery of therapeutic agents
#27TCO conjugates and methods for delivery of therapeutic agents
#28METHODS OF IMAGING WITH Ga-68 LABELED MOLECULES
#29COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF
#30TUMOR THERAPY BY BISPECIFIC ANTIBODY PRETARGETING
#31Immunoconjugates for the treatment of tumours
#32System for Targeted Delivery of Therapeutic Agents
#33TRIFUNCTIONAL AND COMPLETELY CLEARABLE SPECIFIC TARGETING AGENTS AND METHODS THEREOF
#34Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene
#35Bacterial nitroreductase enzymes and methods relating thereto
#36Agents for clearing biomolecules from circulation
#37CANCER IMAGING WITH THERAPY: THERANOSTICS
#38Pretargeting kit, method and agents used therein
#39Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof
#40BISAMINOETHANETHIOL-TARGETING LIGAND CONJUGATES AND COMPOSITIONS
#41Dye Conjugated Peptides for Fluorescent Imaging
#42METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY
#43Therapeutic using a bispecific antibody
#44PRETARGETING KIT, METHOD AND AGENTS USED THEREIN
#45PRETARGETING KIT, METHOD AND AGENTS USED THEREIN
#46Compositions and methods for delivering a substance to a biological target
#47RADIO-LABELED MATERIALS AND METHODS OF MAKING AND USING THE SAME
#48Immunoconjugates for the treatment of tumours
#49System for targeted delivery of therapeutic agents
#50Substituted aryl-fluoroborates as imaging agents
#51METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY
#52Probes for in vivo targeting of active cysteine proteases
#53Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition
#54Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
#55RADIOIMAGING MOIETIES COUPLED TO PEPTIDEASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES
#56Sulfonamide Derivatives Having Carbonic Anhydrase Inhibiting Activity and their Use as Therapeutic and Diagnostic Agents
#57Compositions and methods for detecting and treating tumors containing acidic areas
#58Therapeutic using a bispecific antibody
#59Compositions and methods for enhanced delivery to target sites
#60Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
#61Compounds containing matrix metalloproteinase substrates and methods of their use
#62Antibodies specific for nanotubes and related methods and compositions
#63Immunoconjugates for the treatment of tumours
#64Methods of treating diseases responsive to induction of apoptosis and screening assays